Siebold S.N. de Graaf

2.2k total citations
38 papers, 1.6k citations indexed

About

Siebold S.N. de Graaf is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Siebold S.N. de Graaf has authored 38 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Hematology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Siebold S.N. de Graaf's work include Acute Myeloid Leukemia Research (12 papers), Acute Lymphoblastic Leukemia research (10 papers) and Cancer therapeutics and mechanisms (8 papers). Siebold S.N. de Graaf is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Acute Lymphoblastic Leukemia research (10 papers) and Cancer therapeutics and mechanisms (8 papers). Siebold S.N. de Graaf collaborates with scholars based in Netherlands, United States and Germany. Siebold S.N. de Graaf's co-authors include Keith Wheatley, David Webb, Christine J. Harrison, Donald R. A. Uges, Robert K. Hills, Ian Hann, Brenda Gibson, B Gibson, Elisabeth R. van Wering and Willem A. Kamps and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Siebold S.N. de Graaf

38 papers receiving 1.5k citations

Peers

Countries citing papers authored by Siebold S.N. de Graaf

Since Specialization

Citations

This map shows the geographic impact of Siebold S.N. de Graaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siebold S.N. de Graaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siebold S.N. de Graaf more than expected).

Fields of papers citing papers by Siebold S.N. de Graaf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siebold S.N. de Graaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siebold S.N. de Graaf. The network helps show where Siebold S.N. de Graaf may publish in the future.

Co-authorship network of co-authors of Siebold S.N. de Graaf

This figure shows the co-authorship network connecting the top 25 collaborators of Siebold S.N. de Graaf. A scholar is included among the top collaborators of Siebold S.N. de Graaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siebold S.N. de Graaf. Siebold S.N. de Graaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Results of a randomized trial in children with Acute Myeloid Leukaemia: Medical Research Council AML12 trial 2011 ·British Journal of Haematology ·Brenda Gibson, David Webb, Andrew Howman, Siebold S.N. de Graaf, Christine J. Harrison, Keith Wheatley, (unknown)	142
2	Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique 2010 ·European Journal of Cancer ·Brian V. Balgobind, Iris H.I.M. Hollink, Dirk Reinhardt, Elisabeth R. van Wering, Siebold S.N. de Graaf, André Baruchel, Jan Starý, H. Berna Beverloo, Georgine E. de Greef, Rob Pieters, C. Michel Zwaan, Marry M. van den Heuvel‐Eibrink	16
3	EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia 2010 ·Leukemia ·Brian V. Balgobind, Sanne Lugthart, Iris H.I.M. Hollink, (unknown), Elisabeth R. van Wering, Siebold S.N. de Graaf, Dirk Reinhardt, Ursula Creutzig, Gertjan J.L. Kaspers, Eveline S.J.M. de Bont, Jan Starý, Jan Trka, M Zimmermann, H. Berna Beverloo, Rob Pieters, Ruud Delwel, C. Michel Zwaan, Marry M. van den Heuvel‐Eibrink	57
4	Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol 2010 ·Leukemia ·Vincent H. J. van der Velden, (unknown), B Gibson, Jeroen G. te Marvelde, Patricia G. Hoogeveen, Wim C.J. Hop, Keith Wheatley, Marc Bierings, Gerrit‐Jan Schuurhuis, Siebold S.N. de Graaf, Elisabeth R. van Wering, Jacques J. M. van Dongen	110
5	Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia 2009 ·Blood ·Iris H.I.M. Hollink, Marry M. van den Heuvel‐Eibrink, Martin Zimmermann, Brian V. Balgobind, Susan T.C.J.M. Arentsen-Peters, Mariëlle Alders, André Willasch, Gertjan J.L. Kaspers, Jan Trka, André Baruchel, Siebold S.N. de Graaf, Ursula Creutzig, Rob Pieters, Dirk Reinhardt, C. Michel Zwaan	80
6	Vincristine pharmacokinetics is related to clinical outcome in children with standard risk acute lymphoblastic leukemia 2008 ·British Journal of Haematology ·Gudmar Lönnerholm, Britt‐Marie Frost, Jonas Abrahamsson, Mikael Behrendtz, Anders Castor, Erik Forestier, Mats Heyman, Donald R. A. Uges, Siebold S.N. de Graaf	28
7	Vincristine pharmacokinetics in children with down syndrome 2008 ·Pediatric Blood & Cancer ·Gudmar Lönnerholm, Britt‐Marie Frost, Stefan Söderhäll, Siebold S.N. de Graaf	6
8	Broncholithiasis in an immune compromised boy with disseminated Mycobacteriumkansasii 2007 ·Pediatric Pulmonology ·Inge Cuppen, Wiel C.M. de Lange, Siebold S.N. de Graaf, (unknown), C. Boetes, J.L. Yntema	7
9	Prognostic Significance of Blasts in the Cerebrospinal Fluid Without Pleiocytosis or a Traumatic Lumbar Puncture in Children With Acute Lymphoblastic Leukemia: Experience of the Dutch Childhood Oncology Group 2006 ·Journal of Clinical Oncology ·D. Maroeska W. M. te Loo, Willem A. Kamps, Anna Berg, Elisabeth R. van Wering, Siebold S.N. de Graaf	69
10	Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials 2005 ·Leukemia ·B Gibson, Keith Wheatley, Ian Hann, Richard Stevens, David Webb, Robert K. Hills, Siebold S.N. de Graaf, Christine J. Harrison, (unknown)	206
11	Mycobacterium Reverse Hybridization Line-Probe Assay Used to Diagnose Disseminated Mycobacterium haemophilum Infection in a Child with Acute Lymphoblastic Leukemia 2004 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), Judith M. Deckers‐Kocken, Siebold S.N. de Graaf, (unknown), Willem J. G. Melchers, J. A. A. Hoogkamp‐Korstanje	8
12	Transient cortical blindness following vincristine therapy 2003 ·Medical and Pediatric Oncology ·(unknown), Siebold S.N. de Graaf, Aad Verrips	4
13	Pitfalls of “long‐distance pharmacokinetics.” Shipment of biologic samples to reference laboratories 2002 ·Medical and Pediatric Oncology ·Stewart J. Kellie, Donald R. A. Uges, (unknown), Britt‐Marie Frost, Siebold S.N. de Graaf	2
14	Cerebrospinal fluid concentrations of vincristine after bolus intravenous dosing 2002 ·Cancer ·Stewart J. Kellie, Draga Barbaric, (unknown), John Earl, (unknown), Siebold S.N. de Graaf	48
15	The influence of recombinant human insulin-like growth factor-I (rhIGF-I) on cell growth and cytotoxicity of drugs in childhood rhabdomyosarcoma cell lines and xenograft models 2000 ·Cancer Chemotherapy and Pharmacology ·Corrie Gidding, Glen S. Germain, Michael B. Dilling, (unknown), Richard A. Ashmun, Siebold S.N. de Graaf, Karen A. Veverka, Willem A. Kamps, Peter J. Houghton	10
16	Vincristine pharmacokinetics after repetitive dosing in children 1999 ·Cancer Chemotherapy and Pharmacology ·Corrie Gidding, (unknown), Peter J. Koopmans, Donald R. A. Uges, Willem A. Kamps, Siebold S.N. de Graaf	70
17	Hereditary persistence of alpha-fetoprotein in a child with testicular germ cell tumor 1999 ·Medical and Pediatric Oncology ·Pamela Cochran, Allen R. Chauvenet, P. Suzanne Hart, Siebold S.N. de Graaf, Barbara Cushing, (unknown), Marcia M. Wofford	12
18	Pharmacokinetics of vincristine in children and adolescents with acute lymphocytic leukemia 1994 ·The Journal of Pediatrics ·William R. Crom, Siebold S.N. de Graaf, Timothy W. Synold, Donald R. A. Uges, (unknown), Gaston K. Rivera, Michael Christensen, Hazem H. Mahmoud, William E. Evans	93
19	Estimation of Extracellular Volume in Preterm Infants <1500 g, Children, and Adults by Sucrose Dilution 1990 ·Pediatric Research ·K Bauer, Hans Versmold, (unknown), Siebold S.N. de Graaf, (unknown), Jan G. Zijlstra	8
20	Improved high-performance liquid chromatographic method using loop-column extraction for analysis of idarubicin and idarubicinol in plasma 1989 ·Journal of Chromatography B Biomedical Sciences and Applications ·Siebold S.N. de Graaf, (unknown), William E. Evans	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact